CryoLife Shares Outstanding 2006-2018 | CRY

CryoLife shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • CryoLife shares outstanding for the quarter ending June 30, 2018 were 0.037B, a 10.16% increase year-over-year.
  • CryoLife 2017 shares outstanding were 0.034B, a 4.09% increase from 2016.
  • CryoLife 2016 shares outstanding were 0.033B, a 15% increase from 2015.
  • CryoLife 2015 shares outstanding were 0.029B, a 0.81% increase from 2014.
CryoLife Annual Shares Outstanding
(Millions of Shares)
2017 34
2016 33
2015 29
2014 28
2013 28
2012 27
2011 28
2010 28
2009 28
2008 28
2007 27
2006 25
2005 24
CryoLife Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 37
Q1 2018 36
Q4 2017 34
Q3 2017 34
Q2 2017 34
Q1 2017 34
Q4 2016 33
Q3 2016 33
Q2 2016 33
Q1 2016 32
Q4 2015 29
Q3 2015 29
Q2 2015 28
Q1 2015 28
Q4 2014 28
Q3 2014 28
Q2 2014 28
Q1 2014 28
Q4 2013 28
Q3 2013 28
Q2 2013 27
Q1 2013 27
Q4 2012 27
Q3 2012 27
Q2 2012 27
Q1 2012 28
Q4 2011 28
Q3 2011 28
Q2 2011 28
Q1 2011 28
Q4 2010 28
Q3 2010 28
Q2 2010 28
Q1 2010 29
Q4 2009 28
Q3 2009 28
Q2 2009 28
Q1 2009 28
Q4 2008 28
Q3 2008 29
Q2 2008 28
Q1 2008 28
Q4 2007 27
Q3 2007 28
Q2 2007 26
Q1 2007 26
Q4 2006 25
Q3 2006 25
Q2 2006 25
Q1 2006 25
Q4 2005 24
Q3 2005 24
Q2 2005 24
Q1 2005 24
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.213B $0.190B
CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $92.526B 22.19
Intuitive Surgical (ISRG) United States $59.409B 58.68
Edwards Lifesciences (EW) United States $30.847B 34.74
Fresenius Medical Care (FMS) Germany $24.461B 17.28
IDEXX Laboratories (IDXX) United States $19.425B 59.03
ABIOMED (ABMD) United States $17.351B 142.14
DexCom (DXCM) United States $11.738B 0.00
Teleflex (TFX) United States $11.230B 26.71
Hologic (HOLX) United States $11.184B 19.03
Varian Medical Systems (VAR) United States $9.690B 24.39
STERIS (STE) United Kingdom $9.186B 25.26
Masimo (MASI) United States $6.069B 40.41
LivaNova (LIVN) United Kingdom $5.651B 33.71
Globus Medical (GMED) United States $5.410B 35.99
Integra LifeSciences Holdings (IART) United States $5.403B 27.96
Penumbra (PEN) United States $4.842B 440.13
Inogen (INGN) United States $4.370B 115.63
Cantel Medical (CMD) United States $3.569B 35.95
Wright Medical Group (WMGI) Netherlands $3.017B 0.00
Halyard Health (AVNS) United States $2.877B 23.68
Integer Holdings (ITGR) United States $2.408B 21.80
Glaukos (GKOS) United States $2.175B 0.00
Opko Health (OPK) United States $2.054B 0.00
Tandem Diabetes Care (TNDM) United States $2.053B 0.00
Nevro (NVRO) United States $1.622B 0.00
Mazor Robotics (MZOR) Israel $1.529B 0.00
AxoGen (AXGN) United States $1.359B 0.00
Luminex (LMNX) United States $1.291B 38.07
Tactile Systems Technology (TCMD) United States $1.212B 206.53
K2Ms (KTWO) United States $1.196B 0.00
Orthofix (OFIX) United States $1.071B 32.63
Natus Medical (BABY) United States $1.064B 22.57
TransEnterix (TRXC) United States $0.940B 0.00
Accelerate Diagnostics (AXDX) United States $0.896B 0.00
Intersect ENT (XENT) United States $0.896B 0.00
AngioDynamics (ANGO) United States $0.764B 26.74
ViewRay (VRAY) United States $0.708B 0.00
Mesa Laboratories (MLAB) United States $0.693B 42.86
Sientra (SIEN) United States $0.655B 0.00
Pacific Biosciences Of California (PACB) United States $0.595B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.425B 0.00
OrthoPediatrics (KIDS) United States $0.419B 0.00
Neuronetics (STIM) United States $0.407B 0.00
Quotient (QTNT) Switzerland $0.371B 0.00
Veracyte (VCYT) United States $0.365B 0.00
GenMark Diagnostics (GNMK) United States $0.352B 0.00
Accuray (ARAY) United States $0.319B 0.00
Nuvectra (NVTR) United States $0.314B 0.00
Fluidigm (FLDM) United States $0.311B 0.00
RTI Surgical (RTIX) United States $0.297B 58.63
IRadimed (IRMD) United States $0.281B 101.15
SeaSpine Holdings (SPNE) United States $0.252B 0.00
Corindus Vascular Robotics (CVRS) United States $0.249B 0.00
CRH Medical (CRHM) Canada $0.234B 29.27
T2 Biosystems (TTOO) United States $0.219B 0.00
Helius Medical Technologies (HSDT) United States $0.206B 0.00
Invuity (IVTY) United States $0.178B 0.00
Pulse Biosciences (PLSE) United States $0.176B 0.00
RA MEDICAL SYST (RMED) United States $0.145B 0.00
Apollo Endosurgery (APEN) United States $0.137B 0.00
Alphatec Holdings (ATEC) United States $0.135B 0.00
Ekso Bionics Holdings (EKSO) United States $0.128B 0.00
Viveve Medical (VIVE) United States $0.115B 0.00
Second Sight Medical Products (EYES) United States $0.109B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.104B 0.00
EDAP TMS (EDAP) France $0.081B 0.00
Biosig Technologies (BSGM) United States $0.078B 0.00
Restoration Robotics (HAIR) United States $0.061B 0.00
ConforMIS (CFMS) United States $0.060B 0.00
Electromed (ELMD) United States $0.057B 28.33
Navidea Biopharmaceuticals (NAVB) United States $0.049B 0.00
OBALON THERPTCS (OBLN) United States $0.045B 0.00
Neovasc (NVCN) Canada $0.043B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Vermillion (VRML) United States $0.040B 0.00
Lianluo Smart (LLIT) China $0.034B 0.00
PAVmed (PAVM) United States $0.032B 0.00
Titan Medical (TMDI) Canada $0.029B 0.00
ReWalk Robotics (RWLK) Israel $0.026B 0.00
Presbia (LENS) Ireland $0.025B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
American Shared Hospital Services (AMS) United States $0.019B 15.27
Nanovibronix (NAOV) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.015B 0.00
Avinger (AVGR) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
Amedica (AMDA) United States $0.004B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00